The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity
NCT01692431 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2013-10-16
Summary
The primary aim of this study is to determine the impact of individual fish oil fatty acids on vascular reactivity and to identify underlying physiological and molecular mechanism of any observed effects. In addition response to intervention according to genotype will be determined retrospectively.
Conditions
- Cardiovascular Physiological Phenomena
- Endothelial Nitric Oxide Synthase
- Eicosapentaenoic Acid
- Docosahexaenoic Acid (All-Z Isomer)
Interventions
- DIETARY_SUPPLEMENT
-
EPA
High fat meal containing EPA
- DIETARY_SUPPLEMENT
-
DHA
High fat meal containing DHA
- DIETARY_SUPPLEMENT
-
Placebo
High fat meal containing negligible EPA/DHA content
Sponsors & Collaborators
-
University of East Anglia
lead OTHER
Principal Investigators
-
Anne Marie Minihane, PhD · University of East Anglia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 35 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2013-10-31
- Completion
- 2013-10-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Effects of Omega-3 Fatty Acids on the Human Gene Expression
NCT01089231 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance
NCT03259412 ·Status: COMPLETED ·Phase: NA
-
Fish Oil-derived N-3 Polyunsaturated Fatty Acids and Extracellular Vesicles
NCT03203512 ·Status: COMPLETED ·Phase: NA
-
Clinical Study to Assess High-DHA Fish Oil on Biomarkers of Cardiovascular Disease Risk in Adults on Statin Therapy
NCT01690312 ·Status: COMPLETED ·Phase: NA
-
Vascular Impact of Omega-3 in Metabolic Syndrome
NCT01566188 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids on Markers of Inflammation
NCT01129050 ·Status: COMPLETED ·Phase: NA
-
Fish Oil and Cardiovascular Suboptimal Health
NCT02103517 ·Status: COMPLETED ·Phase: PHASE3
-
Bioavailability of EPA + DHA Enriched Canned Tuna and Its Acute Effects
NCT03742492 ·Status: UNKNOWN ·Phase: PHASE2
-
Differential Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Platelet, Endothelial and Vascular Function
NCT01735357 ·Status: COMPLETED ·Phase: NA
-
Genes, Omega-3 Fatty Acids and Cardiovascular Disease Risk Factors
NCT01343342 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Fish Oil and Biomarkers of Cardiovascular Risk
NCT00527436 ·Status: TERMINATED ·Phase: NA
-
Effect of Omega 3 Fatty Acids on Vascular Function
NCT01888211 ·Status: COMPLETED ·Phase: NA
-
The ALA, DHA and EPA Esters in the Prevention of Cardiovascular Diseases.
NCT04743050 ·Status: UNKNOWN ·Phase: PHASE3
-
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
NCT00360217 ·Status: COMPLETED ·Phase: NA
-
Effect of a Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and Endothelial Progenitor Cells (EPC's)
NCT00166088 ·Status: COMPLETED ·Phase: PHASE2
-
Omega 3 Fatty Acids and Atrial Fibrillation
NCT00508248 ·Status: WITHDRAWN ·Phase: NA
-
Vascular and Metabolic Effects of Omega-3 Fatty Acids
NCT01660932 ·Status: COMPLETED ·Phase: PHASE4
-
Intervention With Omega Fatty Acids in High-risk Patients
NCT02647333 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health
NCT02042274 ·Status: COMPLETED ·Phase: NA
-
Impact of EPA and DHA Supplementation on Plasma Biomarkers of Inflammation (n3)
NCT01810003 ·Status: COMPLETED ·Phase: NA
-
Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance
NCT01215903 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers
NCT00682318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Omega-3 Fatty Acids Supplementation and Atherothrombotic Biomarkers in Type 2 Diabetes and Cardiovascular Disease.
NCT02178501 ·Status: COMPLETED ·Phase: NA
-
Marine Oils and Arthritis
NCT00805116 ·Status: TERMINATED ·Phase: NA
-
A Dose Response Investigation of Docosahexaenoic Acid (DHA)
NCT06294067 ·Status: COMPLETED ·Phase: PHASE1